Fulminant myocarditis after the first dose of mRNA-1273 vaccination in a patient with previous COVID-19: a case report.

Kohei HoriuchiShumpei Kosugi Haruhiko AbeYasunori Ueda

Published in: European heart journal. Case reports (2022)

COVID-19 vaccine-induced myocarditis varies from mild to severe. In the present case, the patient was treated as for fulminant lymphocytic myocarditis and recovered relatively quickly. The mechanism of COVID-19 vaccine-associated myocarditis needs to be urgently investigated.

Keyphrases

coronavirus disease
sars cov
case report
respiratory syndrome coronavirus
hepatitis b virus
endothelial cells